Study: Stop-smoking drugs Chantix, Zyban pose no heart risks

By: AP | Chicago |
Published: April 9, 2018 10:59:54 pm

The original study involved 8,000 smokers randomly assigned to daily use of Pfizer’s Chantix, GlaxoSmithKline’s Zyban, nicotine patches or dummy pills for 12 weeks. (Source: Thinkstock Images)

Two popular stop-smoking drugs are as safe for the heart as nicotine patches and dummy pills, according to research requested by U.S. and European regulators. The results come from an extension of a big study of Chantix and Zyban that earlier found no increased risks for severe psychiatric problems including suicidal behavior. Those findings were reported in 2016. “It’s enormously reassuring,” said Dr Nancy Rigotti, director of the Massachusetts General Hospital Tobacco Research and Treatment Center. She was not involved in the research. We now know it’s a lot safer to use these drugs to help…

Read More



Please enter your comment!
Please enter your name here